Search

everythinglearnresearchcommunity

for

Search:↓

Treating the temple area carefully with combined methods improves facial youthfulness.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

γδ T cells are essential for wound healing after poxvirus infection.

Microemulsions could improve skin drug delivery but face challenges like complex creation and potential toxicity.

Skin cancer often starts from Lgr5+ progenitor cells.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Skin cancer in sun-exposed areas is more likely to come back.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

People with lichen planus have higher bad cholesterol and lower good cholesterol, increasing their risk for heart disease.

Dermoscopic examination helps diagnose different types of hair loss conditions by showing specific patterns.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Some plants with flavonoids may help treat hair loss and promote hair growth.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.